Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society
Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
Nine Mile Metals Announces Completion of DDH WD-26-03, and Confirms Continued Mineralization at the Wedge Deposit
Standard Uranium Confirms Uranium Enrichment in All Winter 2026 Drill Holes at the Corvo Uranium Project
Nevada Sunrise Completes Soil Survey Program at the Fivemile Gold Project, Cortez Mining District, Nevada
Sranan Gold's Lawatino Reconnaissance Sampling Program Returns Grab Sample Assays of up to 101.5 g/t Gold
